Olpasiran, lepodisiran, and zerlasiran

1. Olpasiran, lepodisiran, and zerlasiran decreases lipoprotein in humans (Reductions of up to 80% to 95%).

   ReviewSeparate siRNA-based therapies, not a combination treatmentsmall interfering RNA

   Efficacy and tolerability of targeted lipoprotein(a)-lowering therapies: A systematic review · Journal of clinical lipidology · 26 Aug 2026

Lipoprotein →